| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ann M Rasmusson, Libin Shi, Ronald Duma. Downregulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associated with footshock. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 27. issue 2. 2002-08-07. PMID:12093587. |
possible implications for stress-related and other neuropsychiatric disorders associated with deficits in hippocampal function and volume, such as depression, post-traumatic stress disorder, and alzheimer's disease, are discussed. |
2002-08-07 |
2023-08-12 |
rat |
| U Freo, G Pizzolato, M Dam, C Ori, L Battisti. A short review of cognitive and functional neuroimaging studies of cholinergic drugs: implications for therapeutic potentials. Journal of neural transmission (Vienna, Austria : 1996). vol 109. issue 5-6. 2002-08-06. PMID:12111473. |
hippocampus) processes; such an effect probably is not specific for alzheimer disease and can be beneficial in patients suffering from a wide array of neuropsychiatric disorders. |
2002-08-06 |
2023-08-12 |
human |
| C Höschl, T Haje. Hippocampal damage mediated by corticosteroids--a neuropsychiatric research challenge. European archives of psychiatry and clinical neuroscience. vol 251 Suppl 2. 2002-07-17. PMID:11824844. |
signs of hippocampal damage (hpa dysregulation in combination with memory impairment) are found in affective disorders, alzheimer's disease and in posttraumatic stress disorder. |
2002-07-17 |
2023-08-12 |
Not clear |
| Qi-Sheng Chen, Wei-Zheng Wei, Takeshi Shimahara, Cui-Wei Xi. Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiology of learning and memory. vol 77. issue 3. 2002-07-12. PMID:11991763. |
alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. |
2002-07-12 |
2023-08-12 |
rat |
| Qi-Sheng Chen, Wei-Zheng Wei, Takeshi Shimahara, Cui-Wei Xi. Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiology of learning and memory. vol 77. issue 3. 2002-07-12. PMID:11991763. |
the perforant path projecting from the entorhinal cortex to the hippocampal dentate gyrus is a particularly vulnerable target to the early deposition of amyloid beta (abeta) peptides in alzheimer's brain. |
2002-07-12 |
2023-08-12 |
rat |
| Barry W Festoff, Karen SantaCruz, Paul M Arnold, Cyril T Sebastian, Peter J A Davies, Bruce A Citro. Injury-induced "switch" from GTP-regulated to novel GTP-independent isoform of tissue transglutaminase in the rat spinal cord. Journal of neurochemistry. vol 81. issue 4. 2002-07-12. PMID:12065630. |
we recently found that alternative transcripts of tissue transglutaminase (ttg or tg2) were present in hippocampal brain regions of alzheimer's disease (ad), but not in control, non-demented, age-matched brains. |
2002-07-12 |
2023-08-12 |
rat |
| Michio Hashimoto, Shahdat Hossain, Toshio Shimada, Kozo Sugioka, Hiroshi Yamasaki, Yoshimi Fujii, Yutaka Ishibashi, Jun-Ichiro Oka, Osamu Shid. Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. Journal of neurochemistry. vol 81. issue 5. 2002-07-09. PMID:12065621. |
docosahexaenoic acid pre-administration furthermore increased cortico-hippocampal reduced glutathione levels and glutathione reductase activity, and suppressed the increase in lipid peroxide and reactive oxygen species levels in the cerebral cortex and hippocampus of the alzheimer's disease model rats, suggesting an increase in antioxidative defence. |
2002-07-09 |
2023-08-12 |
rat |
| Xue Ying He, Guang Yeong Wen, George Merz, Dawei Lin, Ying Zi Yang, Penkaj Mehta, Horst Schulz, Song Yu Yan. Abundant type 10 17 beta-hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimer's disease model. Brain research. Molecular brain research. vol 99. issue 1. 2002-07-02. PMID:11869808. |
abundant type 10 17 beta-hydroxysteroid dehydrogenase in the hippocampus of mouse alzheimer's disease model. |
2002-07-02 |
2023-08-12 |
mouse |
| Xue Ying He, Guang Yeong Wen, George Merz, Dawei Lin, Ying Zi Yang, Penkaj Mehta, Horst Schulz, Song Yu Yan. Abundant type 10 17 beta-hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimer's disease model. Brain research. Molecular brain research. vol 99. issue 1. 2002-07-02. PMID:11869808. |
high levels of this enzyme may disrupt steroid hormone homeostasis in synapses and contribute to synapse loss in the hippocampus of the mouse alzheimer's disease model. |
2002-07-02 |
2023-08-12 |
mouse |
| K M Gosche, J A Mortimer, C D Smith, W R Markesbery, D A Snowdo. An automated technique for measuring hippocampal volumes from MR imaging studies. AJNR. American journal of neuroradiology. vol 22. issue 9. 2002-06-27. PMID:11673162. |
kgmap-determined volumes strongly correlated with those obtained with manual tracings and neurofibrillary pathologic findings of alzheimer disease in the hippocampus. |
2002-06-27 |
2023-08-12 |
human |
| K M Gosche, J A Mortimer, C D Smith, W R Markesbery, D A Snowdo. Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study. Neurology. vol 58. issue 10. 2002-06-17. PMID:12034782. |
hippocampal volume as an index of alzheimer neuropathology: findings from the nun study. |
2002-06-17 |
2023-08-12 |
Not clear |
| K M Gosche, J A Mortimer, C D Smith, W R Markesbery, D A Snowdo. Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study. Neurology. vol 58. issue 10. 2002-06-17. PMID:12034782. |
to determine whether hippocampal volume is a sensitive and specific indicator of alzheimer neuropathology, regardless of the presence or absence of cognitive and memory impairment. |
2002-06-17 |
2023-08-12 |
Not clear |
| Wolfgang Block, Frank Jessen, Frank Träber, Sebastian Flacke, Christoph Manka, Rolf Lamerichs, Ewald Keller, Reinhard Heun, Hans Schil. Regional N-acetylaspartate reduction in the hippocampus detected with fast proton magnetic resonance spectroscopic imaging in patients with Alzheimer disease. Archives of neurology. vol 59. issue 5. 2002-06-07. PMID:12020267. |
regional n-acetylaspartate reduction in the hippocampus detected with fast proton magnetic resonance spectroscopic imaging in patients with alzheimer disease. |
2002-06-07 |
2023-08-12 |
Not clear |
| M Mikkonen, H Soininen, I Alafuzof, R Miettine. Hippocampal plasticity in Alzheimer's disease. Reviews in the neurosciences. vol 12. issue 4. 2002-06-06. PMID:11783717. |
hippocampal plasticity in alzheimer's disease. |
2002-06-06 |
2023-08-12 |
Not clear |
| T Kratzsch, J Peters, L Frölic. [Etiology and pathogenesis of Alzheimer dementia]. Wiener medizinische Wochenschrift (1946). vol 152. issue 3-4. 2002-06-05. PMID:11925775. |
disturbance in the cerebral glucose metabolism, especially in the hippocampal regions, is a further proposed factor in the pathogenesis of alzheimer's disease. |
2002-06-05 |
2023-08-12 |
Not clear |
| Egemen Savaskan, Gianfranco Olivieri, Fides Meier, Lena Brydon, Ralf Jockers, Rivka Ravid, Anna Wirz-Justice, Franz Müller-Spah. Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer's disease patients. Journal of pineal research. vol 32. issue 1. 2002-05-20. PMID:11841602. |
increased melatonin 1a-receptor immunoreactivity in the hippocampus of alzheimer's disease patients. |
2002-05-20 |
2023-08-12 |
human |
| M Yamazaki, N Sakura, K Chiba, T Mohr. Prevention of the neurotoxicity of the amyloid beta protein by genipin. Biological & pharmaceutical bulletin. vol 24. issue 12. 2002-05-14. PMID:11767124. |
genipin, which was shown in our previous investigation to have prominent neuritogenic activity in paraneurons such as pc12h cells, was studied to determine whether it could prevent the toxicity of alzheimer's amyloid beta protein (abeta) in cultured hippocampal neurons. |
2002-05-14 |
2023-08-12 |
Not clear |
| Do Hoon Kim, Martha E Payne, Robert M Levy, James R MacFall, David C Steffen. APOE genotype and hippocampal volume change in geriatric depression. Biological psychiatry. vol 51. issue 5. 2002-05-13. PMID:11904138. |
apolipoprotein e has been associated with hippocampal volume loss in alzheimer's disease and in elderly controls. |
2002-05-13 |
2023-08-12 |
human |
| J Wegiel, I Kuchna, T Wisniewski, M J de Leon, B Reisberg, T Pirttila, T Kivimaki, T Lehtimak. Vascular fibrosis and calcification in the hippocampus in aging, Alzheimer disease, and Down syndrome. Acta neuropathologica. vol 103. issue 4. 2002-05-07. PMID:11904752. |
vascular fibrosis and calcification in the hippocampus in aging, alzheimer disease, and down syndrome. |
2002-05-07 |
2023-08-12 |
human |
| J Wegiel, I Kuchna, T Wisniewski, M J de Leon, B Reisberg, T Pirttila, T Kivimaki, T Lehtimak. Vascular fibrosis and calcification in the hippocampus in aging, Alzheimer disease, and Down syndrome. Acta neuropathologica. vol 103. issue 4. 2002-05-07. PMID:11904752. |
study of the hippocampal formation of 82 subjects, including 25 control subjects from 33 to 83 years of age, 34 subjects with alzheimer disease (ad) from 65 to 89 years of age, and 23 subjects with down syndrome (ds) from 33 to 72 years of age, revealed hippocampal vasculopathy with fibrosis and calcification (vfc) in 40% of control, 59% of ad, and 4% of ds subjects. |
2002-05-07 |
2023-08-12 |
human |